MAPT and amyotrophic lateral sclerosis: Beyond this, the evidence for alterations in tau metabolism in ALS has been scant and largely limited to individual case reports or unique inherited disorders in which ALS has been described amongst a broader range of neurological and neuropathological deficits or in association with rare MAPT mutations (82–87).